Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

In Vitro Study of the Anthelminthic Property of Artemesia monosperma grown in Egypt

Abstract

THE various species of the genus Artemesia have been subjected to pharmacological investigation for the purpose of ascertaining their useful application as therapeutic agents. As there was no mention in the literature to the physiological activity of the santoninfree, Artemesia monosperma, Del.1, it was deemed of interest to investigate this common Egyptian desert plant for any possible anthelminthic properties. It was decided that investigations should be made in vitro to determine the effects of some preparations of the plant on both Ascaris and the intestine, and to show whether it possesses a vermicidal or vermifugal property.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Fahmy, I. R., Ahmed, Z. F., and Abdel Moneim, F. (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

SHARAF, A., AHMED, Z. & MONEIM, F. In Vitro Study of the Anthelminthic Property of Artemesia monosperma grown in Egypt. Nature 184, 647 (1959). https://doi.org/10.1038/184647a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/184647a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing